Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ENDRA Life Sciences (NDRA) Income towards Parent Company (2016 - 2025)

ENDRA Life Sciences has reported Income towards Parent Company over the past 6 years, most recently at -$3.1 million for Q4 2021.

  • Quarterly Income towards Parent Company fell 37.94% to -$3.1 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was -$11.2 million through Dec 2021, up 4.22% year-over-year, with the annual reading at -$7.0 million for FY2025, 38.93% up from the prior year.
  • Income towards Parent Company was -$3.1 million for Q4 2021 at ENDRA Life Sciences, down from -$2.7 million in the prior quarter.
  • Over five years, Income towards Parent Company peaked at -$741623.0 in Q1 2017 and troughed at -$4.8 million in Q4 2019.
  • The 5-year median for Income towards Parent Company is -$2.7 million (2019), against an average of -$2.6 million.
  • Year-over-year, Income towards Parent Company plummeted 280.96% in 2018 and then soared 53.2% in 2020.
  • A 5-year view of Income towards Parent Company shows it stood at -$2.3 million in 2017, then decreased by 3.09% to -$2.4 million in 2018, then crashed by 103.3% to -$4.8 million in 2019, then soared by 53.2% to -$2.3 million in 2020, then tumbled by 37.94% to -$3.1 million in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Income towards Parent Company are -$3.1 million (Q4 2021), -$2.7 million (Q3 2021), and -$3.2 million (Q2 2021).